Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000946644-13-000006
Filing Date
2013-05-08
Accepted
2013-05-08 15:18:47
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q heb-2013331x10q.htm 10-Q 789130
2 EXHIBIT 31.1 heb-2013331xex311.htm EX-31.1 13063
3 EXHIBIT 31.2 heb-2013331xex312.htm EX-31.2 13126
4 EXHIBIT 32.1 heb-2013331xex321.htm EX-32.1 6427
5 EXHIBIT 32.2 heb-2013331xex322.htm EX-32.2 6508
  Complete submission text file 0000946644-13-000006.txt   6182626

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT heb-20130331.xml EX-101.INS 1014968
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT heb-20130331.xsd EX-101.SCH 40436
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT heb-20130331_cal.xml EX-101.CAL 64812
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT heb-20130331_def.xml EX-101.DEF 161245
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT heb-20130331_lab.xml EX-101.LAB 471790
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT heb-20130331_pre.xml EX-101.PRE 276877
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27072 | Film No.: 13824242
SIC: 2836 Biological Products, (No Diagnostic Substances)